Trials / Completed
CompletedNCT01070966
Vytorin Reexamination Study (0653A-174)
Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of VYTORIN in Usual Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,089 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
This survey is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the clinical usefulness of VYTORIN through collecting the safety and efficacy information according to the Re-examination Regulation for New Drugs.
Conditions
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2010-02-18
- Last updated
- 2022-02-09
- Results posted
- 2011-05-10
Source: ClinicalTrials.gov record NCT01070966. Inclusion in this directory is not an endorsement.